Goldman Sachs’s Icosavax, Inc. Common Stock ICVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-295,984
| Closed | -$4.66M | – | 5010 |
|
|
2023
Q4 | $4.66M | Buy |
295,984
+267,148
| +926% | +$4.21M | ﹤0.01% | 2643 |
|
|
2023
Q3 | $223K | Sell |
28,836
-36,177
| -56% | -$280K | ﹤0.01% | 4216 |
|
|
2023
Q2 | $646K | Sell |
65,013
-290
| -0.4% | -$2.88K | ﹤0.01% | 3846 |
|
|
2023
Q1 | $379K | Buy |
65,303
+53,354
| +447% | +$309K | ﹤0.01% | 4221 |
|
|
2022
Q4 | $94.9K | Sell |
11,949
-27,607
| -70% | -$219K | ﹤0.01% | 4686 |
|
|
2022
Q3 | $125K | Sell |
39,556
-29,709
| -43% | -$93.9K | ﹤0.01% | 4862 |
|
|
2022
Q2 | $397K | Buy |
69,265
+50,937
| +278% | +$292K | ﹤0.01% | 4529 |
|
|
2022
Q1 | $129K | Sell |
18,328
-2,390
| -12% | -$16.8K | ﹤0.01% | 5231 |
|
|
2021
Q4 | $474K | Buy |
+20,718
| New | +$474K | ﹤0.01% | 4562 |
|